A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Similar documents
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

ACRIN 6666 Therapeutic Surgery Form

Breast pathology. 2nd Department of Pathology Semmelweis University

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Breast Pathology. Breast Development

BREAST PATHOLOGY. Fibrocystic Changes

Image guided core biopsies:

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Papillary Lesions of the breast

Basement membrane in lobule.

How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Protocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

A215- Urinary bladder cancer tissues

NEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA

Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.

Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

Surgical Pathology Issues of Practical Importance

Table of contents. Page 2 of 40

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Recent advances in breast cancers

Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast

Protocol for the Examination of Resection Specimens From Patients With Invasive Carcinoma of the Breast

NAME/ AGE/57 SEX/Female AREA/Australia Visit 1: 5/8/2011. Right Breast Cancer Infiltrating Ductal Carcinoma, no specific type, Grade 1 to 2.

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

RSNA, /radiol Appendix E1. Methods

Breast Cancer. Saima Saeed MD

Invasive Papillary Breast Carcinoma

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Definition of Synoptic Reporting

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Papillary Lesions of the Breast: WHO Update

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

PRINCIPLES OF BREAST SURGERY & COMPLICATIONS

BREAST PATHOLOGY MCQS

Handout for Dr Allison s Lectures on Grossing Breast Specimens:

Promise of a beautiful day

BREAST PATHOLOGY GROSSING GUIDELINES

Overview of AJCC 8 th Staging in Pathologic Aspects

Immunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy

A218 : Esophagus cancer tissues. (formalin fixed)

Collaborative approach to national implementation of Standardization Pathology Reporting. June 2014 Avril Kwiatkowski

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help:

Diseases of the breast (1 of 2)

Pathology Report Patient Companion Guide

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY

Evaluation of Breast Specimens Removed by Needle Localization Technique

BREAST SURGERY PROGRESS TEST Name:

Cytyc Corporation - Case Presentation Archive - March 2002

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

American Journal of Cancer Case Reports. Invasive Papillary Carcinoma of Male Breast: A Rare Case Report

Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Clinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Case Report Synchronous Bilateral Solid Papillary Carcinomas of the Breast

VULVAR CARCINOMA. Page 1 of 5

Breast Surgery: Yesterday, Today and Tomorrow

In Situ Breast Carcinoma. James L. Connolly, M.D Beth Israel Deaconess Medical Center Professor of Pathology Harvard Medical School Boston, MA

Tata Memorial Centre s opinion is summarized as follows:

Lobular Carcinoma In Situ Variants in Breast Cores

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Breast cancer incidence. Multidisciplinary Management in Breast Cancer. Outline. The Breast 11/10/2014. Incidence of breast cancer in Thailand

Breast Cancer. Dr. Andres Wiernik 2017

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Papillary Lesions of the Breast

Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina

BreastScreen Aotearoa Annual Report 2015

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

A301 VI- Various cancer tissues with corresponding normal tissues

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Completing the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017

CASE REPORT GASTRIC ADENOCARCINOMA METASTASIS TO THE BREAST- A DIFFERENTIAL DIAGNOSIS WITH PRIMARY BREAST ADENOCARCINOMA AND REVIEW OF LITERATURE.

A DEEPER DIVE INTO DUCTAL CARCINOMA IN SITU: CLINICAL AND PATHOLOGIC CONSIDERATIONS IN 2015

Diseases of the breast (2 of 2) Breast cancer

December 2002 Monthly Memo

Toru Nakamura 1, Takashi Fukutomi 1, Hitoshi Tsuda 2, Sadako Akashi-Tanaka 1, Kaneyuki Matsuo 1, Chikako Shimizu 1 and Kunihisa Miyakawa 3

A201(VI)- Various cancer tissues

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters

Journal of Breast Cancer

TOTALS 30. Preliminary analysis of NNDEQA 004 (May 2013 TSL workshops) 1) 70 year old female with focal irregularity in the right breast.

What is the recommended regimen for adjuvant radiation therapy? Tata Memorial Centre s opinion is summarized as follows:

Transcription:

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding normal tissues No. of spots: 1 spot from each cancer case (12 spots) 12 non-neoplastic spots (12 spots) Total spots: 24 Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm Documents: Product specification: layout, summary of tissue spots H&E stained images Detailed pathological information Layout: P-07-04-10T

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues Summary of tissue spots (formalin fixed) For research use only P-07-04-11T

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only QC sheet_lot# 132121104111 Hematoxylin and Eosin staining A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5 E1 E2 F1 F2 P-07-04-12T

1 A 1 f 49 Breast, right, total mastectomy with SLNB: 1. 1) Size: 2.8x1.9cm 2) Black's nuclear grade: 1 (poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) Intraductal component: 15% 5) Resection margins: Negative 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present in invasive cancer, in associated with benign epithelium, in stroma 9) Immunohistochemistry: ER(+), PR(+), C erb B2 (weak +:2+/3+) 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, sentinel(0/4), axillary(0/3), regional(0/2):(0/9): Free of tumor. 2 B 1 f 49 non-neoplastic non-neoplastic from A1 3 A 2 f 66 Breast, left, modified radical mastectomy: 1.Status incisional biopsy with residual invasive ductal 1) Size of the residual tumor: 2x1.8cm 2) Site: LO quadrant 3) Black's nuclear grade: I (poorly differentiated) 4) Modified Bloom-Richardson's histological grade: III 5) Intraductal component: 10% 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present, In invasive cancer, In DCIS, In association with benign epithelium 9) Immunohistochemistry: ER(-), PR(+), C erb B2(-: 0/3+) 2.Nipple and areola: Free of tumor 3.Lymph node, sentinel(2/2), axillary(2/24):(4/26):tumor metastasis in 4 out of 26 nodes 4 B 2 f 66 non-neoplastic non-neoplastic from A2

5 A 3 f 45 Breast, left, modified radical mastectomy: 1. 1) Size: 3x2cm 2) Black's nuclear grade: I (poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) EIC:present 5) Resection margins: Negative 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present in invasive cancer and ductal in situ 9) Immunohistochemistry: ER(focal +), PR(-), C erb B2(+:3+/3+) 10)Back ground ductal in situ 1 Nuclear grade: high 2 Histologic grade: high 3 Necrosis: Present (comedo) 4 Architecture type: Cribriform, solid 5 Extent of ductal in situ: about 8x5cm 6 Calcification: Present in ductal in situ 7 Microinvasion: Present 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, axillary(2/31):tumor metastasis in 2 out of 31 nodes (with pericapslar tumor spread: largest size of tumor deposit: 3.3x2.5cm) 6 B 3 f 45 non-neoplastic non-neoplastic from A3

7 A 4 f 58 Breast, left, modified radical mastectomy: 1. 1) Size: 1.5x1.3cm and 0.5x0.3cm(each separated by 1.5cm) 2) Black's nuclear grade: 1(poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) EIC: Present 5) Vascular invasion: Present 6) Perineural invasion: Absent 7) Microcalcification: Absent 8) Immunohistochemistry: ER(-), PR(-), C erb B2(-: 0/3+) 9) Ductal in situ in the background 1. Nuclear grade: high 2. Histological grade: intermediate 3. Necrosis: absent 4. Architectural types: cribriform, solid 5. Extent of DCIS: 4x3cm 6. Calcification: absent 10) Associated benign changes: Fibrocystic change with florid ductal epithelial hyperplasia. 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, axillary(2/35): Tumor metastasis in 2 out of 35 nodes (without pericapsular tumor spread)(size of the largest metastatic tumor: 1.5x1.0mm) 8 B 4 f 58 non-neoplastic non-neoplastic from A4

9 A 5 f 50 non-neoplastic Breast, ringht, skin sparing total mastectomy: 1. Size: 3x3x2cm 2. Black's nuclear grade: 1 (poorly differentiated) 4. EIC: Present 6. Vascular invasion: Absent 8. Microcalcification: Present in association with benign epithelium Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, axillary(0/3): Free of tumor. Breast, labelled as "subareolar subcutaneous tissue", excision: Free of tumor. Result of immunohistochemical stains: ER(+), PR(+), C erb B2(weak +: 2+/3+) 10 B 5 f 50 non-neoplastic non-neoplastic from A5 11 C 1 f 69 Breast, right, partial mastectomy: 1. Size: 2.2x1.3cm 2. Black's nuclear grade: 1 (poorly differentiated) 3. Modified Bloom-Richardson's histological grade:iii 4. Intraductal component: 10% 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in ductal in situ 9. ER(+), PR(+), C erb B2(weak+:2+/3+) Underlying fascia: Free of tumor. Lymph node, sentinel(0/2): Free of tumor. 12 D 1 f 69 non-neoplastic non-neoplastic from C1

13 C 2 f 58 Breast, right, modified radical mastectomy: 1. Size: 2.2x1.3cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: positive 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in associated with benign epithelium, in stroma 9. Immunohistochemistry: ER(-), PR(-), C erb B2(-:0+/3+) 10. Showing histologic changes of adjuvant chemotherapy 11. Associated benign changes: Fibroadenoma. Nipple and areola: Free of tumor. Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, axillary(0/7): Free of tumor. 14 D 2 f 58 non-neoplastic non-neoplastic from C2

15 C 3 f 59 Breast, left, total mastectomy: 1. Size: 2.3x1.8cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: positive 6. Vascular invasion: Absent 7. Perineural invasion: Present 8. Microcalcification: Present in invasive cancer, in ductal in situ, in associated with benign epithelium, in stroma 9. ER(-), PR(-), C erb B2(+:3+/3+) Nipple and areola: Paget's disease. Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, sentinel(0/4):free of tumor 16 D 3 f 59 non-neoplastic non-neoplastic from C3

17 C 4 f 46 Breast, left, partial mastectomy: 1. Size: 2.2x1.7cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: Present Distance to closest (relevant) margin: 2mm Relevant margin is superior 6. Vascular invasion: Present 8. Microcalcification: Present in invasive cancer, in ductal in situ, in associated with benign epithelium, in stroma 9. Immunohistochemistry: ER(-), PR(+), C erb B2(-:0/3+) 10. Ductal in situ in the background 1) Nuclear grade: High 2) Histological grade: High 3) Necrosis: Present (Comedo) 4) Architectural types: Solid 5) Extent of DCIS: 9x6cm 6) Microinvasion: Absent (multifocal) Lymph node, sentinel(0/2): Free of tumor. 18 D 4 f 46 non-neoplastic non-neoplastic from C4

19 C 5 f 39 20 D 5 f 39 non-neoplastic non-neoplastic from C5 Breast, left, partial mastectomy: mixed with mucinous 1. Size: 2.2x1.8cm 2. Black's nuclear grade: I (poorly differentiated) 4. Intraductal component: No 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in associated with benign epithelium 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:0/3+) Note: About 60-70% of the tumor consists of mucinous and this case cannot be categories as pure mucinous. E 1 f 39 Breast, left(upper outer), partial mastectomy: mixed with mucinous 1. Size: 2x1cm 2. Black's nuclear grade: II (moderately differentiated) 4. Intraductal component: No 6. Vascular invasion: Present 8. Microcalcification: Absent 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:1+/3+), Synaptophysin (focal +), chromogranin(-), NSE(-) Lymph node, sentinel (1/1), axillary (4/18): (5/19): Tumor metastasis in 5 out of 19 nodes. (size of the largest metastatic tumor: 1.8x1.5 cm) with perinodal tumor spread Note: About 40-50% of the tumor consists of mucinous. 22 F 1 f 39 non-neoplastic non-neoplastic from E1

23 E 2 f 46 Breast, left, partial mastectomy: 1. Size: 1.4x1.3cm 2. Black's nuclear grade: 1 (poorly differentiated) 4. Intraductal component: < 5% 5. With areas of invasive micropapillary 6. Vascular invasion: Present 8. Microcalcification: Absent 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:0/3+ ) Lymph node, sentinel (1/4), axillary (0/4): (1/8): Tumor metastasis in one out of 8 nodes with focal perinodal tumor spread. (size of the metastatic tumor: 2x1mm) 24 F 2 f 46 non-neoplastic non-neoplastic from F1